Townsend Richard Nolan

Reporting owner on Forms 3, 4 and 5, CIK 1995218.

Townsend Richard Nolan reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-28.

Issuers

Issuer	Roles in the latest filing	Filings	Last filed
Lexeo Therapeutics, Inc. CIK 1907108	director, officer (Chief Executive Officer)	1	2026-09-28

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

Security	Date	Code	Shares	Price	Owned after	Filing
Lexeo Therapeutics, Inc. Stock Option (right to buy), derivative	2026-09-24	A granted	+145,500	$0	145,500	Form 4
Lexeo Therapeutics, Inc. Common Stock	2026-09-14	A granted	+2,306	$2.644	376,778	Form 4

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

Filing	Subject	Filed	Accepted	Ingested
Form 4 0001995218-26-000017	Lexeo Therapeutics, Inc.	2026-09-28	2026-09-28 21:15:06 UTC	2026-10-06 10:11:32 UTC